Department of Infectious Disease and Global Health, Tufts Cummings School of Veterinary Medicine, North Grafton, Massachusetts, USA.
Department of Infectious Disease and Global Health, Tufts Cummings School of Veterinary Medicine, North Grafton, Massachusetts, USA.
Int J Parasitol. 2021 Aug;51(9):761-775. doi: 10.1016/j.ijpara.2021.01.003. Epub 2021 Mar 25.
Despite the public health impact of childhood diarrhea caused by Cryptosporidium, effective drugs and vaccines against this parasite are unavailable. Efforts to identify vaccine targets have focused on critical externally exposed virulence factors expressed in the parasite s invasive stages. However, no single surface antigen has yet been found that can elicit a significant protective immune response and it is likely that pooling multiple immune targets will be necessary. Discovery of surface proteins on Cryptosporidium sporozoites is therefore vital to this effort to develop a multi-antigenic vaccine. In this study we applied a novel single-domain camelid antibody (VHH) selection method to identify immunogenic proteins expressed on the surface of Cryptosporidium parvum sporozoites. By this approach, VHHs were identified that recognize two sporozoite surface-exposed antigens, the previously identified gp900 and an unrecognized immunogenic protein, Cp-P34. This Cp-P34 antigen, which contains multiple Membrane Occupation and Recognition Nexus (MORN) repeats, is found in excysted sporozoites as well as in the parasite s intracellular stages. Cp-P34 appears to accumulate inside the parasite and transiently appears on the surface of sporozoites to be shed in trails. Identical or nearly identical orthologs of Cp-P34 are found in the Cryptosporidium hominis and Cryptosporidium tyzzeri genomes. Except for the conserved MORN motifs, the Cp-P34 gene shares no significant homology with genes of other protozoans and thus appears to be unique to Cryptosporidium spp. Cp-P34 elicits immune responses in naturally exposed alpacas and warrants further investigation as a potential vaccine candidate.
尽管隐孢子虫引起的儿童腹泻对公众健康有影响,但目前仍缺乏针对这种寄生虫的有效药物和疫苗。寻找疫苗靶点的努力集中在寄生虫侵袭阶段表达的关键外部暴露的毒力因子上。然而,尚未发现能够引起显著保护免疫反应的单一表面抗原,很可能需要汇集多个免疫目标。因此,发现隐孢子虫孢子虫表面蛋白对于开发多抗原疫苗的努力至关重要。在这项研究中,我们应用了一种新的单域骆驼抗体(VHH)选择方法来鉴定表达在微小隐孢子虫孢子虫表面的免疫原性蛋白。通过这种方法,鉴定出了识别两种孢子虫表面暴露抗原的 VHH,即先前鉴定的 gp900 和一种未被识别的免疫原性蛋白 Cp-P34。这种 Cp-P34 抗原含有多个膜占据和识别连接(MORN)重复序列,存在于脱囊的孢子虫以及寄生虫的细胞内阶段。Cp-P34 似乎在寄生虫内部积累,并短暂出现在孢子虫表面,然后以痕迹的形式脱落。在人隐孢子虫和微小隐孢子虫基因组中发现了与 Cp-P34 相同或几乎相同的同源物。除了保守的 MORN 基序外,Cp-P34 基因与其他原生动物的基因没有显著同源性,因此似乎是隐孢子虫属所特有的。Cp-P34 在自然暴露的羊驼中引起免疫反应,值得进一步研究作为潜在的疫苗候选物。